Argus
•
Sep 02, 2026
SDGR: Raising target price to $22.00
Summary
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: CRISPR Therapeutics AG
Aug 19, 2026
•
CRSP
Daily – Vickers Top Buyers & Sellers for 08/17/2026
Aug 17, 2026
•
ANGX, MEDP, MTDR, KRYS, NP, ABCL, RSG, RL, CURB, CODI
Analyst Report: Intellia Therapeutics, Inc.
Aug 11, 2026
•
NTLA
Analyst Report: CRISPR Therapeutics AG
Aug 05, 2026
•
CRSP
Analyst Report: Guardant Health, Inc.
Jul 31, 2026
•
GH
